TCL Archive In Brief: Hatch Bill Would Relax Delaney Clause; Malone Names Acting NIH Head; Search Committee Formed July 17, 1981
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Cancer Program Bill Renews Congressional Commitment To Principles, Rep. Carter Says May 5, 1978
